[HTML][HTML] Transforming Growth Factor-β1 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome

K Aihara, Y Ikeda, S Yagi, M Akaike… - … research and practice, 2011 - hindawi.com
Transforming growth factor-β1 (TGF-β1) is a polypeptide member of the transforming growth
factor β superfamily of cytokines. It is a secreted protein that performs many cellular functions …

n-3 polyunsaturated fatty acids: promising nutrients for preventing cardiovascular disease

S Yagi, D Fukuda, K Aihara, M Akaike… - … of atherosclerosis and …, 2017 - jstage.jst.go.jp
The adoption of the Western-style diet, with decreased fish intake and lack of exercise, has
increased the prevalence of cardiovascular disease (CVD) in Japan. Statin treatment has …

Suppressive function of androgen receptor in bone resorption

H Kawano, T Sato, T Yamada… - Proceedings of the …, 2003 - National Acad Sciences
As locally converted estrogen from testicular testosterone contributes to apparent androgen
activity, the physiological significance of androgen receptor (AR) function in the beneficial …

Brain masculinization requires androgen receptor function

T Sato, T Matsumoto, H Kawano… - Proceedings of the …, 2004 - National Acad Sciences
Testicular testosterone produced during a critical perinatal period is thought to masculinize
and defeminize the male brain from the inherent feminization program and induce male …

[HTML][HTML] Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice

K Aihara, H Azuma, M Akaike, Y Ikeda… - Journal of Biological …, 2004 - ASBMB
Vitamin D metabolites influence the expression of various genes involved in calcium
homeostasis, cell differentiation, and regulation of the immune system. Expression of these …

Vitamin D receptor in osteoblasts is a negative regulator of bone mass control

Y Yamamoto, T Yoshizawa, T Fukuda… - …, 2013 - academic.oup.com
The physiological and beneficial actions of vitamin D in bone health have been
experimentally and clinically proven in mammals. The active form of vitamin D [1α, 25 (OH) …

Effect of aspirin treatment on serum concentrations of lipoprotein (a) in patients with atherosclerotic diseases

M Akaike, H Azuma, A Kagawa, K Matsumoto… - Clinical …, 2002 - academic.oup.com
Background: Increased serum lipoprotein (a)[Lp (a)] is an independent risk factor for
atherosclerosis. We previously reported that aspirin reduced Lp (a) production by cultured …

[HTML][HTML] Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis

Y Ikeda, K Aihara, T Sato, M Akaike… - Journal of Biological …, 2005 - ASBMB
Androgen has anabolic effects on cardiac myocytes and has been shown to enhance left
ventricular enlargement and function. However, the physiological and patho-physiological …

[HTML][HTML] Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus

S Yagi, Y Hirata, T Ise, K Kusunose, H Yamada… - Diabetology & metabolic …, 2017 - Springer
Background It is unknown whether canagliflozin, a selective sodium glucose co-transporter
2 inhibitor, reduces epicardial adipose tissue (EAT) thickness, which is associated with …

Association of accumulated advanced glycation end‐products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes

H Mori, A Kuroda, M Ishizu, M Ohishi… - Journal of diabetes …, 2019 - Wiley Online Library
Abstract Aims/Introduction Advanced glycation end‐products (AGEs), which are a major
cause of diabetic vascular complications, accumulate in various tissues under chronic …